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Dr Francis C. Nichols (Rochester, Minn). In 1915, an eventual
president of this association and the Mayo Clinic’s first thoracic sur-
geon, Samuel Robinson, wrote, and I quote, ‘‘Certain thoracic dis-
eases, which for generations have fallen to the lot of the surgeons,
are yet badly handled. Conspicuous among these is the patriarch
of the surgical scrap-heap, chronic empyema.’’ Dr Robinson then
went on to say that there is obvious opportunity for improvement
in the treatment of this disease, and I think that remains true today.
Prevention remains the most effective method of dealing with PPE
and BPF, and as we all know, among these preventative measures
are avoidance of contamination of the pleural space during pneumo-
nectomy and not leaving the bronchial stump too long while at the
same point in time not devascularizing the stump and the prophylac-
tic reinforcement of the stump in the face of what I call hostile
conditions, namely radiation and certain infections. Despite these
precautions, these problems continue to occur.184 The Journal of Thoracic and Cardiovascular Surgery c JulyIn our most recent series, we reviewed 84 patients with PPE over
a 16-year period of time. Our mortality was 7%, and our median hos-
pital stay was 30 days. Therefore you and your colleagues are to be
commended on the results of your management. Although every
death is a tragedy, the 4% mortality you report is noteworthy;
with median follow-up of almost 21ˇ/2 years, your ultimately success-
ful treatment of 97% of the patients is also commendable, and be-
cause your median hospital stay is 18 days, that is enviable.
As we all know and have heard, improvements in the manage-
ment of this disease have occurred, including the Clagett procedure
and its modification, whereby living tissue is transposed into the tho-
racic space. We believe that muscles of the chest wall are ideal for
transposing into the chest because all are large enough and long
enough to reach most intrathoracic locations. Most frequently we
choose the serratus anterior, the latissimus dorsi when it is still avail-
able, and the pectoralis major muscles. Given our success with these
muscles, we have rarely used omentum because we would like to
avoid opening the contaminated abdominal cavity.
I have a few questions. I would like to focus first on the BPFs.
Forty-four of your patients (ie, 58%) had a BPF. You stated that if
a BPF was present, you protected the contralateral lung. We believe
the protection of the contralateral lung is actually paramount in all
cases and use a single-lumen endotracheal tube to block off the re-
maining main stem bronchus or a double-lumen tube. Some of the
fistulae you saw were small and might have only been detected in
the operating room. Of the 44 BPFs, how many were only identified
in the operating room?
Dr Schneiter. Dr Nichols, thank you for your questions, and
thank you for your comments.
As you expected, we use mostly a double-lumen endotracheal
tube and rarely a single-lumen tube, which is positioned into the re-
maining main bronchus during anesthesia to protect the stump but
especially the contralateral lung. All BPFs were suspected in the
clinical or radiologic presentation, but 5 of them were tiny and
only detected during the operation by applying air pressure to the
water-submerged stump.
DrNichols. This leads to my next question. Focusing on the sub-
set of BPF, 9 patients, as you put it, had pinhole insufficiency, in
which merely the pinhole was sutured and protected with surround-
ing tissue. There were 10 patients who ultimately experienced recur-
rent empyema, and 6 of those 10 had BPFs found at re-exploration.
Howmany of these 6 came from this pinhole and local tissue control
group? Additionally, what do you mean by local tissue because
these chests are usually very scarred and inflamed?
Dr Schneiter. You are absolutely right that it is impossible to
use any local tissue in late-occurring empyemas because of the
explanation you just gave. In 2 of these 6 patients with recurrence
of the BPF, both only a few days after definitive closure in the first
attempt, a pericardial fat flap was used for covering. We used peri-
cardial fat in another 3 patients without further complications.
Dr Nichols. You transposed omentum in 18 cases, a variety of
muscle flaps in 11 cases, a pericardial fat pad in 5 cases, and an azy-
gos vein actually in 1 case. Therefore of the 6 BPFs, how many of
those actually had soft tissue coverage in the first place? I think
you might have just answered part of the question, but what failed?
Dr Schneiter. There was failure in 2 in which the pericardial fat
flap was applied. The other 3 with the same type of coverage healed
fine. Therefore we believe that in very early cases of empyema2008
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can be applied as a first choice when a well-vascularized pericardial
fat flap can be prepared. However, in Zurich we use the omentum as
the first choice with excellent success, which is in contrast to our
colleagues in Szczecin, who prefer to apply extrathoracic muscle
coverage.
Dr Nichols. I am intrigued by your use of omentum. In your
manuscript you failed to talk about operative morbidity. Were there
any intra-abdominal complications related to the use of the omen-
tum, peritonitis in particular?
Dr Schneiter. Surprisingly, we did not observe peritonitis or any
wound infection or any other abdominal complications in our
patients.
Dr Nichols. In the manuscript you talk about repeatedly closing
the skin. You had amedian of 3 repeat pack changes, and as opposed
to most of us who would just pack the chest open, you actually close
the skin, I am assuming with sutures or clips, and now based on your
presentation, you actually place a drain. In essence, you are sort of
doing a wound VAC-type approach. Is that right?
Dr Schneiter. That is right. We fill the chest with povidone-
soaked dressings, one drain between the dressings and the lateral
chest wall, and we adapt the ribs and close the fascia but leave the
muscle layer untouched until the final closure. The skin is closed
with staplers. The patient receives an elastic rib belt not only applied
during mobilization but also during bed rest.
Dr Nichols. Do you maintain suction on this closure?
Dr Schneiter. Yes, a constant suction of25 to210 cm of water
is applied, which might give a VAC-type effect to the cavity.
Dr Nichols. Finally, the median hospital stay of 18 days is truly
enviable. The median number of days, however, from the final
closure to hospital discharge was almost 2 weeks. Why were the
patients hospitalized so long after final wound closure?
Dr Schneiter. Actually, in most European hospitals patients are
treated in the hospital until they are well recovered without drains
and able to go back home. In the North American system, I would
expect that these patients would be treated ambulatory 2 to 5 days
after final closure. Maybe we will do this as well for cost reasons
in the future.
Dr Nichols. Again, thank you for the opportunity to discuss this
paper, and I commend you on your results.
Dr Schneiter. Thank you very much.
Dr Erino Rendina (Rome, Italy). Again, congratulations on an
excellent paper and on an innovative approach to this problem,
which all of us are obliged to face.
I have a few questions. You mentioned that several of your pa-
tients had undergone pleuropneumonectomy for mesothelioma,
and that implies that those patients must have had some kind of pros-
thesis in their chests. How did you handle this? Did you have to
remove the diaphragmatic prosthesis or the pericardial prosthesis?
Dr Schneiter. Actually, there were 5 patients who had pleural
pneumonectomy, and in all of them, we did remove the pericardial
prosthesis we put in because we saw some kind of infection area
around this, but we never took out the diaphragmatic prosthesis.
Dr Rendina. Thank you. There might be a high variability of
general conditions in these patients; in particular, sepsis might dete-
riorate the clinical conditions and put patients at risk for repeatedThe Journal of Thsurgical procedures. Did you have patients who could not undergo
such an aggressive approach because of their compromised general
condition, fever, and sepsis? In other words, was any patient with
empyema that you observed over the study period excluded from
your cohort?
Dr Schneiter. Actually, we operated on all patients in the same
way.We did not do an alternative approach. But you are right. There
have been patients in a very ill status when they came.We were a lit-
tle bit surprised as well that after the first intervention, once you have
taken out the infected tissue, the patient is doing better very quickly.
And the second intervention is a very short one. It is just opening,
changing the dressings, doing an aggressive debridement again,
and repacking it with this dressing. It takes between 45 minutes
and maybe an hour. Actually, we never saw a problem.Wewere sur-
prised as well at the beginning that it works. Actually, we never had
a problem.
Dr Rendina. Finally, I concur with you that a very small pinhole
fistula can be closed right away at the first procedure. What about
larger fistulae in which the wall of the bronchus is fragile and would
not hold the sutures?Would you close it at the first procedure or wait
for the tissue integrity to be restored and buttress the suture in a later
procedure?
Dr Schneiter. Actually, it depended a little bit on the size of the
hole. If the hole is too big, then we can just pack it with these dress-
ings, and we have to be afraid that maybe some of the leakage spills
on the other side, and then we tried to cover it or to close it in the first
attempt. If the hole was not so big, we might have done it also in the
second attempt, but usually we did it in the first. And if the hole was
big and we could not close it, we did directly suture the omentum on
the hole. We did not close the hole. We directly put it on the hole.
Dr Rendina. Thank you. Congratulations again.
Dr Joel D. Cooper (Philadelphia, Pa). I want to congratulate the
authors on what I think is a great contribution.
I first heard about this sort of thing 20-some years ago when Mi-
chael Perlman from Moscow told me that they had done 75 cases
with almost universal success, and they did it with an ultrasonic gen-
erator. He said they would gradually fill the chest and add the gen-
erator until the water boiled as a form of debridement. His friends
joked that he was killing the spine of the bacteria, but I am not
sure that I believed him. I thought maybe something was lost in
translation. However, when I visited Zurich and saw some of these
patients and when I hear this presentation, I think it is a great contri-
bution. I think that you have established or at least confirmed the fact
that it is possible to take an infected chest and in virtually a single
stage, notwithstanding the few trips to the operating room, shorten
the whole process, when most of us, including myself, still put these
patients through a Clagett window, a cleanup procedure, and a filling
with tissue. I think this is a very important principle that you have
confirmed. I have one minor addition. On a few cases, when there
has been a small fistula, a little postage stamp of Surgicel with fibrin
glue put over the fistula and then reinforced with fibrin glue and then
omentum or muscle over it and then a packing gives a very good clo-
sure without air blowing up the flap. I have never done it the way
you have. I have always done it staged. But I think it is a great con-
tribution, and my congratulations to you on a good presentation.
Dr Schneiter. Thank you very much, Professor Cooper.oracic and Cardiovascular Surgery c Volume 136, Number 1 185
